Floatz logo

Ganciclovir

Cytomegalovirus Infections

City of Hope Medical CenterSmall moleculePhase 3Active
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Cytomegalovirus Infections cohort.

Asset / SponsorPhaseRating
Foscarnet
City of Hope Medical Center
Phase 4BB
Valganciclovir
The Methodist Hospital Research Institute
Phase 3BB
Letermovir
Fernanda P Silveira, MD, MS
Phase 2B
Cmvpp65-A*0201 Peptide Vaccine
City of Hope Medical Center
Phase 2B
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
City of Hope Medical Center
Phase 2CCC

View all 16 →

Same molecule, other indications

Ganciclovir is also rated in:

cytomegalovirus retinitisDormant
A
Indicative ·
82 / 100
View asset →
HIV infectious diseaseDormant
BBB
Indicative ·
76 / 100
View asset →
lymphomaDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →